OPKO Health, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by OPKO Health, Inc. on April 21, 2022. The filing addresses compensation matters approved by the Compensation Committee of the Board of Directors during a meeting held on the same date.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It is limited to specific executive compensation adjustments.
Material Changes
The Compensation Committee approved the following changes to executive compensation:
- Dr. Jon R. Cohen (Senior Vice President): Approved a cash bonus payment of $1,150,000 and an annual salary increase from $575,000 to $600,000.
- Mr. Adam Logal (SVP, CFO, CAO, and Treasurer): Approved a cash bonus payment of $200,000.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on operations, risks, contingencies, or unusual items beyond the specific compensation approvals detailed above.
Investor Verification Points
- Verify the total cash outflow of $1,350,000 in bonuses and the $25,000 annual salary increase for Dr. Cohen.
- Confirm the impact of these compensation adjustments on the company's upcoming quarterly operating expenses.
- Review the company's cash position to ensure liquidity is sufficient to cover these immediate cash payments.